{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:35:52Z","timestamp":1789504552725,"version":"build-2803163510"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007957","name":"Chongqing Municipal Education Commission","doi-asserted-by":"publisher","award":["KJQN202200451"],"award-info":[{"award-number":["KJQN202200451"]}],"id":[{"id":"10.13039\/501100007957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-MSX0086"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX0086"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002865","name":"Chongqing Science and Technology Commission","doi-asserted-by":"publisher","award":["CSTB2024NSCQ-MSX0621"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0621"]}],"id":[{"id":"10.13039\/501100002865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.ijbiomac.2025.143759","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T02:07:29Z","timestamp":1746151649000},"page":"143759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P2","title":["A dual-peptides and specific promoter-modified nano gene delivery system for myocardial hypertrophy treatment"],"prefix":"10.1016","volume":"311","author":[{"given":"Yangchen","family":"Xing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongjie","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kexin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongjun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiqi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huali","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ijbiomac.2025.143759_bb0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.143759_bb0010","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12371","article-title":"Engineered small extracellular vesicle-mediated NOX4 siRNA delivery for targeted therapy of cardiac hypertrophy","volume":"12","author":"Kang","year":"2023","journal-title":"J. Extracell. Vesicles"},{"issue":"24","key":"10.1016\/j.ijbiomac.2025.143759_bb0015","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.111.048785","article-title":"Pak1 as a novel therapeutic target for antihypertrophic treatment in the heart","volume":"124","author":"Liu","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2018.01.008","article-title":"Secretoneurin suppresses cardiac hypertrophy through suppression of oxidant stress","volume":"822","author":"Chen","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0030","article-title":"Therapeutic peptides: current applications and future directions","volume":"7(1):48","author":"Wang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143759_bb0035","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrd4363","article-title":"Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies","volume":"13","author":"Mitragotri","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0040","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2015.08.001","article-title":"Cardiac gene therapy: recent advances and future directions","volume":"215","author":"Mason","year":"2015","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143759_bb0045","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCRESAHA.118.311587","article-title":"Human cardiac gene therapy","volume":"123","author":"Ishikawa","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0050","article-title":"Recent advances in targeting the \u201cundruggable\u201d proteins: from drug discovery to clinical trials","volume":"8(1):335","author":"Xie","year":"2023","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0055","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jconrel.2024.03.018","article-title":"Plasmid DNA ionisable lipid nanoparticles as non-inert carriers and potent immune activators for cancer immunotherapy","volume":"369","author":"Qin","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0060","article-title":"Plasmid DNA for therapeutic applications in cancer","volume":"14(9):1861","author":"Mart\u00ednez-Puente","year":"2022","journal-title":"Pharmaceutics"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.143759_bb0065","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1038\/mt.2012.79","article-title":"In vivo gene delivery by nonviral vectors: overcoming hurdles?","volume":"20","author":"Zhang","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0070","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jconrel.2021.08.002","article-title":"Advance cardiac nanomedicine by targeting the pathophysiological characteristics of heart failure","volume":"337","author":"Lin","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114414","article-title":"Recent advances in biomimetic nanodelivery systems for the treatment of myocardial ischemia reperfusion injury","volume":"247","author":"Bi","year":"2025","journal-title":"Colloids Surf. B: Biointerfaces"},{"issue":"43","key":"10.1016\/j.ijbiomac.2025.143759_bb0080","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1093\/eurheartj\/ehac463","article-title":"Small non-coding RNA therapeutics for cardiovascular disease","volume":"43","author":"Shah","year":"2022","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.143759_bb0085","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.7150\/thno.26284","article-title":"Nanoparticles for diagnosis and therapy of atherosclerosis and myocardial infarction: evolution toward prospective theranostic approaches","volume":"8","author":"Bejarano","year":"2018","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143759_bb0090","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/gt.2008.135","article-title":"Gene delivery into ischemic myocardium by double-targeted lipoplexes with anti-myosin antibody and TAT peptide","volume":"16","author":"Ko","year":"2009","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143759_bb0095","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1021\/mp300500y","article-title":"Targeted gene delivery to ischemic myocardium by homing peptide-guided polymeric carrier","volume":"10","author":"Won","year":"2013","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143759_bb0100","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1080\/10717544.2020.1754525","article-title":"In vitro and in vivo evaluation of liposomes modified with polypeptides and red cell membrane as a novel drug delivery system for myocardium targeting","volume":"27","author":"Liu","year":"2020","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143759_bb0105","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1080\/10717544.2016.1253121","article-title":"PCM and TAT co-modified liposome with improved myocardium delivery: in vitro and in vivo evaluations","volume":"24","author":"Wang","year":"2017","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.143759_bb0110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/nrm.2017.115","article-title":"Transcription regulation by the mediator complex","volume":"19","author":"Soutourina","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.143759_bb0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/sj.gt.3301618","article-title":"Tumor-specific transcriptional targeting of suicide gene therapy","volume":"9","author":"Qiao","year":"2002","journal-title":"Gene Ther."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.143759_bb0120","doi-asserted-by":"crossref","first-page":"18979","DOI":"10.1074\/jbc.M201257200","article-title":"Cardiomyocyte-specific gene expression following recombinant adeno-associated viral vector transduction","volume":"277","author":"Aikawa","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143759_bb0125","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/gt.2011.18","article-title":"Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure","volume":"18","author":"Sundararaman","year":"2011","journal-title":"Gene Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.143759_bb0130","doi-asserted-by":"crossref","first-page":"H1439","DOI":"10.1152\/ajpheart.01090.2001","article-title":"Left ventricular targeting of reporter gene expression in vivo by human BNP promoter in an adenoviral vector","volume":"283","author":"LaPointe","year":"2002","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.143759_bb0135","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jgm.1576","article-title":"A single direct injection into the left ventricular wall of an adeno-associated virus 9 (AAV9) vector expressing extracellular superoxide dismutase from the cardiac troponin-T promoter protects mice against myocardial infarction","volume":"13","author":"Prasad","year":"2011","journal-title":"J. Gene Med."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0140","article-title":"PINK1 phosphorylates Drp1S616 to improve mitochondrial fission and inhibit the progression of hypertension-induced HFpEF","volume":"23(19):11934","author":"Shou","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"23","key":"10.1016\/j.ijbiomac.2025.143759_bb0145","doi-asserted-by":"crossref","first-page":"e471","DOI":"10.1161\/CIR.0000000000001296","article-title":"Gene therapy in cardiovascular disease: recent advances and future directions in science: a science advisory from the American Heart Association","volume":"150","author":"Kim","year":"2024","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143759_bb0150","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCRESAHA.118.311587","article-title":"Human cardiac gene therapy","volume":"123","author":"Hajjar","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejpb.2022.12.002","article-title":"Preparation and characterization of a gemini surfactant-based biomimetic complex for gene delivery","volume":"182","author":"Lu","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0160","article-title":"Gene-delivery ability of new hydrogenated and partially fluorinated Gemini bispyridinium surfactants with six methylene spacers","volume":"23(6):3062","author":"Massa","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0165","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jconrel.2024.08.019","article-title":"Enhanced delivery of CRISPR\/Cas9 system based on biomimetic nanoparticles for hepatitis B virus therapy","volume":"374","author":"Wu","year":"2024","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.143759_bb0170","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/sj.gt.3300596","article-title":"Time-dependent maturation of cationic liposome-DNA complex for serum resistance","volume":"5","author":"Yang","year":"1998","journal-title":"Gene Ther."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.143759_bb0175","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0168-3659(01)00415-1","article-title":"Stability of PEI-DNA and DOTAP-DNA complexes: effect of alkaline pH, heparin and serum","volume":"76","author":"Moret","year":"2001","journal-title":"J. Control. Release"},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.143759_bb0180","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/clinchem\/45.12.2129","article-title":"RNA expression of cardiac troponin T isoforms in diseased human skeletal muscle [published correction appears in Clin Chem 2000 Mar;46(3):437]","volume":"45","author":"Ricchiuti","year":"1999","journal-title":"Clin. Chem."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143759_bb0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/sctm.20-0223","article-title":"Rabbit neurospheres as a novel in vitro tool for studying neurodevelopmental effects induced by intrauterine growth restriction","volume":"10","author":"Barenys","year":"2021","journal-title":"Stem Cells Transl. Med."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.143759_bb0195","doi-asserted-by":"crossref","DOI":"10.5812\/ircmj.16664","article-title":"Effects of losartan and vanillic acid co-administration on ischemia-reperfusion-induced oxidative stress in isolated rat heart","volume":"16","author":"Dianat","year":"2014","journal-title":"Iran Red Crescent Med J"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.143759_bb0200","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/jps.20627","article-title":"In vitro hemolysis: guidance for the pharmaceutical scientist","volume":"95","author":"Amin","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0205","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.3389\/fphys.2019.01529","article-title":"Cholesterol deficiency causes impaired osmotic stability of cultured red blood cells","volume":"10","author":"Bernecker","year":"2019","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.143759_bb0210","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41565-021-00858-8","article-title":"Key principles and methods for studying the endocytosis of biological and nanoparticle therapeutics","volume":"16","author":"Rennick","year":"2021","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143759_bb0215","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1021\/nn100816s","article-title":"Surface-charge-dependent cell localization and cytotoxicity of cerium oxide nanoparticles","volume":"4","author":"Asati","year":"2010","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.143759_bb0220","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.biomaterials.2011.12.027","article-title":"Gene transfer by chemical vectors, and endocytosis routes of polyplexes, lipoplexes and lipopolyplexes in a myoblast cell line","volume":"33","author":"Billiet","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2025.143759_bb0225","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.addr.2015.01.003","article-title":"Are caveolae a cellular entry route for non-viral therapeutic delivery systems?","volume":"91","author":"Rewatkar","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.143759_rf0230","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nrm2122","article-title":"The multiple faces of caveolae","volume":"8","author":"Parton","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.143759_rf0235","doi-asserted-by":"crossref","first-page":"R402","DOI":"10.1016\/j.cub.2017.11.075","article-title":"Caveolae","volume":"28","author":"Parton","year":"2018","journal-title":"Curr. Biol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.143759_rf0240","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jconrel.2010.01.036","article-title":"Endocytosis of nanomedicines","volume":"145","author":"Sahay","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.143759_rf0245","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.addr.2019.08.004","article-title":"Brief update on endocytosis of nanomedicines","volume":"144","author":"Patel","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.143759_rf0250","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nrm3512","article-title":"Caveolae as plasma membrane sensors, protectors and organizers","volume":"14","author":"Parton","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.143759_bb0240","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1021\/mp200583d","article-title":"Polyplexes traffic through caveolae to the Golgi and endoplasmic reticulum en route to the nucleus","volume":"9","author":"Reilly","year":"2012","journal-title":"Mol. Pharm."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.143759_rf0260","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1002\/jcb.24178","article-title":"Shaping the nucleus: factors and forces","volume":"113","author":"Walters","year":"2012","journal-title":"J. Cell. Biochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.143759_rf0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00018-015-2052-6","article-title":"The endoplasmic reticulum: structure, function and response to cellular signaling","volume":"73","author":"Schwarz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.143759_bb0250","doi-asserted-by":"crossref","first-page":"R487","DOI":"10.1016\/j.cub.2018.01.073","article-title":"The dynamic nature of the nuclear envelope","volume":"28","author":"De Magistris","year":"2018","journal-title":"Curr. Biol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.143759_bb0255","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1161\/01.RES.0000129178.56294.17","article-title":"Caveolae and caveolins in the cardiovascular system","volume":"94","author":"Gratton","year":"2004","journal-title":"Circ. Res."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025043119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025043119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T07:16:38Z","timestamp":1762240598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025043119"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":54,"alternative-id":["S0141813025043119"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143759","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A dual-peptides and specific promoter-modified nano gene delivery system for myocardial hypertrophy treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.143759","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"143759"}}